Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Business Alignment PCLBKK:BIZ-R -0.83%91 ROC (Joel Greenblatt) % is 54.55% as of Jun. 2026, which is 23% above its 10-year median of 44.30. GuruFocus rates BKK:BIZ-R with a GF Score™ of 91/100 and a GF Value™ of ฿5.44. The stock has 5 warning signs investors should review. Among 837 Medical Devices & Instruments companies, Business Alignment PCL ranks better than 91.4% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Business Alignment PCL's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2026 was 54.55%.
The historical rank and industry rank for Business Alignment PCL's ROC (Joel Greenblatt) % or its related term are showing as below:
BKK:BIZ-R'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 9.35 Med: 44.3 Max: 75.31
Current: 63.55
During the past 11 years, Business Alignment PCL's highest ROC (Joel Greenblatt) % was 75.31%. The lowest was 9.35%. And the median was 44.30%.
BKK:BIZ-R's ROC (Joel Greenblatt) % is ranked better than 91.4% of 837
companies
in the Medical Devices & Instruments industry
Industry Median: 5.08
vs BKK:BIZ-R: 63.55
Business Alignment PCL's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 28.70% per year.
Business Alignment PCL (BKK:BIZ-R) ROC (Joel Greenblatt) % Explanation
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
Business Alignment PCL ROC (Joel Greenblatt) % Related Terms
Business Alignment PCL ROC (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Business Alignment PCL's ROC (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Business Alignment PCL ROC (Joel Greenblatt) % Chart
BKK:BIZ-R vs ABT, SYK, MDT: ROC (Joel Greenblatt) % Comparison
For the Medical Devices subindustry, Business Alignment PCL's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Business Alignment PCL ROC (Joel Greenblatt) % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Business Alignment PCL's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Business Alignment PCL's ROC (Joel Greenblatt) % falls into.
Business Alignment PCL ROC (Joel Greenblatt) % Calculation
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is four times the quarterly (Jun. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 54.55% mean?
Business Alignment PCL (BKK:BIZ-R) has a ROC (Joel Greenblatt) % of 54.55% as of Jun. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Business Alignment PCL and its competitors. This is 23% above median its historical median of 44.30. Over the past decade, Business Alignment PCL's ROC (Joel Greenblatt) % has ranged from 9.35 to 75.31. According to the industry distribution chart, Business Alignment PCL ranks #72 out of 837 companies in the Medical Devices & Instruments industry, placing it in the top 8.6%.
Is Business Alignment PCL's ROC (Joel Greenblatt) % too high?
Business Alignment PCL's current ROC (Joel Greenblatt) % of 54.55% is 23% above median its 10-year median of 44.30. Over the past 10 years, this metric has ranged from a low of 9.35 to a high of 75.31. The Medical Devices & Instruments industry median ROC (Joel Greenblatt) % is 5.08. Business Alignment PCL's value of 54.55% is 973.8% above this industry median. Based on the distribution chart, Business Alignment PCL ranks #72 out of 837 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Business Alignment PCL has a GF Score™ of 91/100, reflecting its overall financial health beyond just this single metric.
How does Business Alignment PCL's ROC (Joel Greenblatt) % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Business Alignment PCL ranks #72 out of 837 companies for ROC (Joel Greenblatt) %. This places Business Alignment PCL in the top 9% of its industry — outperforming the majority of peers. The industry median ROC (Joel Greenblatt) % is 5.08. Business Alignment PCL's value of 54.55% is 973.8% above this benchmark. Historically, Business Alignment PCL's own ROC (Joel Greenblatt) % has ranged from 9.35 to 75.31 over the past decade. While the company's 10-year median is 44.30 vs. the industry median of 5.08, Business Alignment PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Medical Devices & Instruments company?
The median ROC (Joel Greenblatt) % among Medical Devices & Instruments companies is 5.08, based on 837 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Business Alignment PCL's current ROC (Joel Greenblatt) % of 54.55% is 973.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Business Alignment PCL and its competitors. For the Medical Devices & Instruments industry, the median ROC (Joel Greenblatt) % is 5.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Business Alignment PCL's current ROC (Joel Greenblatt) % is 54.55%, which is 23% above median its own 10-year median of 44.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Business Alignment PCL stock overvalued right now?
Business Alignment PCL (BKK:BIZ-R) has a current ROC (Joel Greenblatt) % of 54.55%. The stock's GF Value™ is ฿5.44, compared to a current price of ฿5.95 — trading 9.4% above its estimated fair value. The current ROC (Joel Greenblatt) % is 54.55%, which is 23% above median its 10-year median of 44.30 and 973.8% above the Medical Devices & Instruments industry median of 5.08. Business Alignment PCL's overall GF Score™ is 91/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Business Alignment PCL (BKK:BIZ-R), the current ROC (Joel Greenblatt) % is 54.55% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Business Alignment PCL (BKK:BIZ-R) Overvalued in 2026?
Based on GuruFocus' analysis, Business Alignment PCL stock appears to be overvalued.
The current stock price of ฿5.95 is trading 9.4% above its estimated GF Value™ of ฿5.44.
Key valuation signals for BKK:BIZ-R:
ROC (Joel Greenblatt) %: 54.55% (23% above median its 10-year median of 44.30)
GF Value™: ฿5.44 vs. price of ฿5.95 (9.4% above fair value)
Industry Position: 973.8% above the Medical Devices & Instruments median (#72 of 837)
No single metric tells the full story. See the BKK:BIZ-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Business Alignment PCL is engaged in the distribution and installation of medical equipment for cancer treatment through radiotherapy. The company operates through the sale of medical equipment segment which includes installation, repair, and maintenance. In addition, it also focuses on increasing the efficiency of medical equipment; and Hospital operations (specialized in cancer treatment). The company is a distributor for Radiotherapy products and Brachytheraphy products in Thailand and Cambodia. Geographically, it operates in the region of Thailand.
91GF Score
Get the complete analysis for BKK:BIZ-R
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:BIZ-R has been successfully added to your 
